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I
n patients with COPD, physiologic measures such as FEV 1 do not correlate strongly with patients' perceptions of their health. In addition, physiologic measures may fail to detect important changes in health status in clinical trials. [1] [2] [3] Therefore, healthrelated quality of life (HRQL) outcomes are gaining importance in clinical trials. The increased interest of regulatory agencies in HRQL assessment for the approval of new therapies reflects this growing importance. 4, 5 The chronic respiratory questionnaire (CRQ) 6 and the St. George's respiratory questionnaire (SGRQ) 7 provide useful assessments of HRQL in patients with COPD and are widely used in clinical trials. 8 -10 Optimizing the ability of the CRQ and SGRQ to detect change (responsiveness) is important to avoid missing small but important treatment-mediated differences. Ensuring that HRQL instruments measure what they are intended to measure (validity) is important to avoid misleading conclusions.
In prior work, 11, 12 we have demonstrated that informing patients of their previous responses to the CRQ (informed administration) may improve the validity and responsiveness of the instrument. In the two relevant studies, 11, 12 the patients completed the CRQ at 2-week intervals. These findings have led investigators to use the informed version of the CRQ, even if the time span between the baseline and follow-up administration is considerably Ͼ 2 weeks. 13 There are at least two reasons why further evaluation of the impact of informed administration of the CRQ and other HRQL instruments remains desirable. First, studies with longer recall times, sometimes based on interventions of longer duration, are less likely to show differences between informed and blind administration. Therefore, investigators may gain little by administering the informed version when the time span between baseline and follow-up administration exceeds a certain length. Second, other investigators have not attempted the replication of our earlier results, using either the CRQ or other HRQL instruments. Replication is particularly important because informed administration has been adopted for other HRQL measures in COPD. 13 The use of informed administration adds a major logistic burden to the use of HRQL questionnaires. Making prior responses available at follow-up complicates interviewer administration and is even more challenging for self-administered questionnaires. These considerations become particularly compelling in multicenter randomized trials. Were investigations to show that informed administration consistently improves their measurement properties, the widespread implementation of informed administration would represent a revolution in HRQL measurement.
Therefore, to establish their relative validity and responsiveness, we conducted a randomized trial of the blind and informed administration of the CRQ and the SGRQ over a 3-month period in the setting of a respiratory rehabilitation program. To evaluate the longitudinal validity of the informed and blind administration techniques of these two questionnaires, we also administered other HRQL instruments used in patients with COPD.
Materials and Methods

Patients
We enrolled patients into the study who were undergoing respiratory rehabilitation at two university centers. 14 We excluded patients who were unable to complete the questionnaires due to language or cognitive limitations, and those with a diagnosis of ␣ 1 -antitrypsin deficiency, silicosis, sarcoidosis, asbestosis, lupus, or cancer.
HRQL Instruments
We administered the following HRQL instruments: blind or informed CRQ and SGRQ 6, 7 ; the Short Form-36 (SF-36) 15 ; the standard gamble (SG) 16 ; the feeling thermometer (FT) 16 ; the health utilities index 3 (HUI3) 17 ; the psychological adjustment to illness scale (PAIS) 18 ; the social impact profile (SIP) 19 ; the transition dyspnea index (TDI) 20 ; and the global ratings of change (GR⌬). 21 The interview lasted 90 to 120 min.
Study Design
We randomized patients to the informed or the blind administration of both the CRQ and SGRQ. In the informed administration, we reminded patients of their previous response using the following phrase at the end of each question: "keeping in mind that the last time you answered the questionnaire you chose . . . ". Initial interviews took place on the day of the patient's admission to the program, and the follow-up interview took place during a clinic visit 3 months later.
The design of this trial was 2 ϫ 2 factorial, and, in addition to the parallel randomization to the blind or informed CRQ and SGRQ, we randomized patients to the administration of the FT with or without a rating of three marker states prior to performing a rating of their own health. However, this report focuses only on the comparison between the informed and the blind administration of the CRQ and the SGRQ. We accounted for possible small effects of order of administration by randomizing patients to complete the HRQL instruments listed above in one of two possible orders. At follow-up, the same interviewer administered or supervised the administration of the instruments to each patient in the same order as at baseline. The administration of the SGRQ, HUI3, TDI, SIP, and PAIS was self-administered and was supervised by the interviewer. All other instruments were administered by the interviewer. For all instruments, we asked patients to rate their health as it had been in the prior 2 weeks.
Statistical Analysis
We performed an analysis of each domain of the CRQ separately and then repeated the analysis after combining the dyspnea and fatigue domains into one physical domain, and combining the mastery and emotional function domains into one emotional domain. Similarly, we analyzed the results of the SGRQ separately for each domain and then combined them into a total score. We tested for the presence of interaction between the blind and informed administration with the format of administering the FT and SG with or without hypothetical health states using analysis of variance and found no statistically significant interaction.
Responsiveness
To assess the relative responsiveness within the groups who received the informed or blind administration of the CRQ, we compared the mean of the baseline and follow-up for the physical and emotional domains using a paired t test. To determine whether any apparent differences in responsiveness could be explained by chance, we compared the difference of the change (⌬) in CRQ scores between the groups receiving blind and informed questionnaire administration using an unpaired t test. We made the same comparisons for each domain and the total score on the SGRQ.
Validity
To evaluate the longitudinal validity of the instruments, we calculated Pearson correlation coefficients for the ⌬ in the CRQ and SGRQ with the other instruments. We calculated these correlations separately for the informed and blind administration of the questionnaires.
Results
Forty-five of the 130 patients initially enrolled into the study did not complete it for the following reasons: patient's refusal to continue the interviewing process (n ϭ 23) or reporting that they were "too sick" to complete the second interview (n ϭ 7); drop-out from the rehabilitation program (n ϭ 6); patient moved out of the region (n ϭ 4); and occurrence of a new symptomatic illness (n ϭ 5). There was no difference in gender, age, length and type of respiratory diagnosis, smoking history, and employment status (the lowest p value on differences between these groups was 0.10) in the patients who completed the trial compared with patients who failed to complete the study. Of the patients who failed to complete the study, 21 were randomized to informed administration, and 24 to blind administration. Table 1 presents the baseline characteristics of the patients randomized to the two intervention arms (informed administration, 42 patients; blind administration, 43 patients) who completed the trial. Patients in the two intervention arms were similar in baseline characteristics although more nonsmokers and patients who were employed were randomized to blind administration. Table 2 shows the ability of the CRQ physical and emotional domains to detect improvement with the rehabilitation program for informed and blind administration. Both groups demonstrated large and statistically significant improvement over the course of rehabilitation. Scores at baseline and follow-up were not significantly different between the blind and informed groups, nor did the magnitude of change differ in the two groups. There was a trend toward greater responsiveness of the informed administration in each of the domains of the CRQ, but the differences were not statistically significant. The differences were smaller for the physical function domains (difference in the mean change for the combined physical function domain, 0.06; 95% confidence interval [CI], Ϫ0.42 to 0.54) than for the emotional function domains (difference in mean change in the overall emotional function domain, 0.25; 95% CI, Ϫ0.24 to 0.73). Table 3 addresses the responsiveness of the SGRQ. At baseline and follow-up, there were no statistically significant differences between the blind and informed administrations. For the SGRQ, a larger reduction in the scores from baseline to follow-up represents greater responsiveness. In contrast to the CRQ, the responsiveness of the SRGQ was lower for each domain of the informed administration compared with the blind administration, but these differences were small and not statistically significant. For the total score, this difference was also not statistically significant (difference in mean change in total score, Ϫ3.2; 95% CI, Ϫ8.3 to 1.8). Table 4 shows the correlations of the change in scores between the CRQ and SGRQ with other instruments. Because there were no differences in the results between the two physical domains of dyspnea and fatigue on the CRQ and the two emotional function domains mastery and emotional function before combining them, we present only the combined physical and emotional domains for the CRQ. There were also no significant differences for the three domains of the SGRQ, and, therefore, we show the total SGRQ score.
Responsiveness
Validity
For both combined domains on the CRQ, the correlations were moderate to strong with few exceptions and were similar for the blind and informed administration techniques. Most of these correla- tions were statistically significant. All GR⌬ questions were correlated with changes in the CRQ and SGRQ scores. Among the preference-based instruments (ie, SG, HUI3, and FT), the FT showed the strongest correlation with the CRQ and SGRQ. The correlations of the generic measures SF-36, SIP, and PAIS were weak. The change in dyspnea, assessed with the TDI, showed moderate-to-strong correlations with the combined CRQ physical domain and the total SGRQ score. Of the 39 correlations in Table 4 , we would expect one to two correlation coefficients to be statistically significantly different between the blind and informed administration at the p Ͻ 0.05 level due to the play of chance. We observed a significant difference between the correlation coefficients only for the correlation between the CRQ physical domain and the SF-36 emotional domain (p ϭ 0.04), and, thus, this difference is likely to be the result of chance. Neither technique led to consistently higher correlations. In 8 of 26 comparisons, the correlation coefficient was higher using the informed technique of the CRQ.
Similarly, blind or informed administration had little influence on the longitudinal validity of the SGRQ total score. In 5 of 13 comparisons the correlation coefficients were higher using the informed technique.
Discussion
We performed a randomized, controlled trial to evaluate the influence of administering the informed version compared to the blind version of two commonly used HRQL instruments (ie, the CRQ and SGRQ) in patients with respiratory disease. We found no statistically significant difference in responsiveness or longitudinal validity when the questionnaires were administered using the informed technique. The trends that did exist (the informed technique was slightly more responsive for the CRQ and slightly less so for the SGRQ) were very weak. These findings have important consequences for clinical trials.
Investigators have not addressed the impact of showing patients their previous responses using the SGRQ, but two previous studies have investigated this question for the CRQ. In an observational study 11 of 13 patients with chronic airflow limitation who had undergone a change in therapy and were re-evaluated after 2 to 6 weeks, we asked the patients to complete first the blind version of the CRQ, and 15 min later, the informed version of the CRQ. In addition, we administered the blind and informed versions of the CRQ in a similar fashion at an interval of 2 weeks to 25 stable patients with chronic airflow limitation and to 18 patients with chronic heart failure who had been referred for specialty care. Although we failed to observe a statistically significant difference in responsiveness in the 13 patients who underwent a change in therapy, in the stable patients the informed technique showed higher reproducibility, that is, a smaller SD of change. We reasoned that reduced variability in unchanged patients might lead to increased responsiveness in a randomized trial setting. We recognized, however, that the administration of the blind version before the informed version may have influenced responses to the latter. In the second study, 12 a randomized crossover trial, results from informed and blind versions of the CRQ showed a similar improvement with ␤-agonist or theophylline therapy after 2-week treatment periods. Informed administration showed higher correlations with changes in spirometry, 6-min walk distance, and postexercise dyspnea. These results suggested that informed administration could improve questionnaire validity.
In the present study, we did not observe superior measurement properties using the informed version when administered after 12 weeks. There are a number of possible explanations. First, the time period between the baseline and follow-up examinations was different from the other two studies. 11, 12 It seems quite plausible that patients' memories of their health status at the first administration fades with time. Improved measurement properties with informed administration rely on the status at the first administration providing an anchor for the interpretation of the questionnaire. If patients no longer have an accurate memory of how they felt at the time of the first questionnaire administration, one would anticipate that informing them of their prior responses would not improve measurement properties.
For example, let us assume that, using a 7-point scale, a patient in the current study chose 4 (moderate shortness of breath while walking upstairs) at the baseline examination. Let us also assume that, when she returns 12 weeks later, the patient has no recollection of her degree of shortness of breath while walking upstairs 12 weeks before. Therefore, she would not remember what level of shortness of breath corresponds to a score of 4. If this is so, reminding her of her score of 4 in answer to this question will not provide her with a comparison or anchor for her current level of dyspnea, because it does not inform her of how short of breath she had felt 12 weeks before. Thus, it is not plausible that informing patients of their prior responses would improve the measurement properties if patients do not remember their prior health state that is associated with scores on the 7-point scale. If she would have remembered how she felt 12 weeks before, and if she also knew that she felt better at the follow-up, she may have chosen a score of 5 after being reminded of her baseline score of 4. The latter, however, was not what we observed in this study, and the fading of memory may be the underlying reason. Twelve weeks may well be enough time for patients' memories of their prior status to fade completely.
A second possibility is that the prior results were anomalous to the crossover designs of the studies in which patients completed both blind and informed versions of the questionnaire. In the parallel group design of the current study, patients completed only one of the two versions of the questionnaires.
We have shown that the administration of the SGRQ in the informed version does not increase responsiveness or longitudinal validity. On the contrary, responsiveness was reduced using the informed technique in all of the SGRQ domains, although this difference was not statistically significant. It is possible that informing patients about previous dichotomous responses (ie, true/false or yes/no) included in the SGRQ but not in the CRQ has no effect on responsiveness due to a lack of graded response options and, moreover, may increase variability and reduce reproducibility. Whether the measurement properties of the SGRQ would improve with informed administration over a shorter recall period remains an open question.
Strengths of the present study include the randomized, parallel-group design that precluded the influence of one format of administration on the other. In addition, the administration of the instruments was highly standardized. Furthermore, the use of an intervention with known effectiveness on HRQL measured with the CRQ and SGRQ 22, 23 ensured that we could compare responsiveness between the informed and blind administration techniques. Finally, the inclusion of multiple other questionnaires allowed us to explore thoroughly the relative validity of the two modes of administration.
A weakness of this study is the relatively high drop-out rate (34.6%). While a variety of factors, including the possibility for memory of fatigue during the baseline interview, might explain the dropout rate, we lost a similar number of patients in both groups, and the characteristics of those who dropped out (and those who remained) were similar in the two groups. In addition, the high correlations (Table 4) for the longitudinal validity of the CRQ and SGRQ would not have occurred if patients had not conscientiously completed the interview.
Another weakness of this study is its limited power to detect small changes. In both the current and the previous trial, 12 we observed the largest difference in responsiveness between the two techniques in the CRQ emotional function domain. In the previous trial, this difference corresponded to a change of approximately 0.19 (combining the effects of the ␤-agonist and theophylline intervention phases) and was statistically significant in the phase of the trial using ␤-agonist therapy only (mean difference, 0.34). In the current trial, we detected a difference between the informed and blind version of the emotional function domain of the CRQ of 0.34 (95% CI, Ϫ0.17 to 0.85) on the 7-point scale in favor of the informed technique. Although the difference was not statistically significant in the current trial, it could still be important for large clinical trials. The fatigue domain showed the smallest difference between the informed and blind CRQ (mean difference, Ϫ0.04; 95% CI, Ϫ0.63 to 0.54).
The minimum important difference in emotional function is approximately 0.5 on a 7-point scale. 24 In large trials, an additional increase of 0.34 in the treatment group compared with the control group in the emotional domain due to informed administration could improve the power appreciably. Moreover, if the true difference between the informed and blind version lies in close proximity to the upper limit of the CI for the emotional domain, the administration of marker states could outweigh the burden of the informed administration.
Examining the CIs represents one way of highlighting the limited strength of inference that follows from our sample size. A power analysis represents another approach to highlighting these limitations. To show that a difference as small as the one observed between the informed and blind CRQ in the emotional function domain at a power of 0.8 and an ␣ of 0.05 was not a chance phenomenon would have required approximately 270 patients. To show a difference as small as the one observed between the informed and blind CRQ in the fatigue domain would have required almost 20,000 patients. The power of the trial was 0.28 to show a difference of 0.3, 0.64 to show a difference of 0.5, and 0.9 to show a difference of 0.7 on the 7-point scale. Looking at either the CIs or the power analysis, we must conclude that our results do not absolutely exclude a benefit of informed administration in selected questionnaire domains over a recall period of as long as 12 weeks.
In summary, administering the informed version of a questionnaire when the hiatus between administrations is short (ie, of the order of 2 weeks) may enhance the reproducibility (and hence the responsiveness) and the validity of the instrument. For longer administration intervals (ie, on the order of 3 months), the informed version may not improve the instrument's measurement properties. However, the time period in which memory is clear and informed administration may be helpful is likely to vary with the circumstances. There also remains the possibility that our study was underpowered to detect a small but important improvement in responsiveness with the informed administration, particularly of the CRQ emotional function domain. We encourage other investigators to explore the impact of blind vs informed administration using varying intervals between administration and other HRQL instruments.
